annual CFI:
-$48.17M-$42.51M(-750.36%)Summary
- As of today (June 19, 2025), RYTM annual cash flow from investing activities is -$48.17 million, with the most recent change of -$42.51 million (-750.36%) on December 31, 2024.
- During the last 3 years, RYTM annual CFI has risen by +$13.99 million (+22.50%).
- RYTM annual CFI is now -130.39% below its all-time high of $158.53 million, reached on December 31, 2020.
Performance
RYTM Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$24.81M+$3.65M(+17.28%)Summary
- As of today (June 19, 2025), RYTM quarterly cash flow from investing activities is $24.81 million, with the most recent change of +$3.65 million (+17.28%) on March 31, 2025.
- Over the past year, RYTM quarterly CFI has dropped by -$5.24 million (-17.43%).
- RYTM quarterly CFI is now -65.79% below its all-time high of $72.52 million, reached on March 31, 2022.
Performance
RYTM quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$53.41M-$5.24M(-10.87%)Summary
- As of today (June 19, 2025), RYTM TTM cash flow from investing activities is -$53.41 million, with the most recent change of -$5.24 million (-10.87%) on March 31, 2025.
- Over the past year, RYTM TTM CFI has dropped by -$59.33 million (-1002.06%).
- RYTM TTM CFI is now -129.92% below its all-time high of $178.53 million, reached on June 30, 2022.
Performance
RYTM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RYTM Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -750.4% | -17.4% | -1002.1% |
| 3 y3 years | +22.5% | -65.8% | -134.2% |
| 5 y5 years | -72.2% | -14.1% | -135.9% |
RYTM Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -271.9% | +22.5% | -65.8% | +126.1% | -129.9% | +22.7% |
| 5 y | 5-year | -130.4% | +22.5% | -65.8% | +117.0% | -129.9% | +22.7% |
| alltime | all time | -130.4% | +56.2% | -65.8% | +117.0% | -129.9% | +74.7% |
RYTM Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.81M(+17.3%) | -$53.41M(+10.9%) |
| Dec 2024 | -$48.17M(+750.4%) | $21.16M(-123.3%) | -$48.17M(+3.2%) |
| Sep 2024 | - | -$90.82M(+960.7%) | -$46.69M(-8.1%) |
| Jun 2024 | - | -$8.56M(-128.5%) | -$50.83M(-958.5%) |
| Mar 2024 | - | $30.05M(+32.7%) | $5.92M(-204.5%) |
| Dec 2023 | -$5.67M(-120.2%) | $22.64M(-123.8%) | -$5.67M(-91.8%) |
| Sep 2023 | - | -$94.96M(-297.0%) | -$69.08M(+400.0%) |
| Jun 2023 | - | $48.19M(+161.0%) | -$13.82M(-46.9%) |
| Mar 2023 | - | $18.46M(-145.3%) | -$26.03M(-192.9%) |
| Dec 2022 | $28.03M(-145.1%) | -$40.77M(+2.7%) | $28.03M(-63.1%) |
| Sep 2022 | - | -$39.70M(-210.3%) | $76.05M(-57.4%) |
| Jun 2022 | - | $35.98M(-50.4%) | $178.53M(+14.4%) |
| Mar 2022 | - | $72.52M(+900.6%) | $156.07M(-351.1%) |
| Dec 2021 | -$62.16M(-139.2%) | $7.25M(-88.5%) | -$62.16M(+726.6%) |
| Sep 2021 | - | $62.78M(+364.2%) | -$7.52M(-78.8%) |
| Jun 2021 | - | $13.53M(-109.3%) | -$35.39M(+120.4%) |
| Mar 2021 | - | -$145.71M(-335.4%) | -$16.05M(-110.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $158.53M(-666.8%) | $61.89M(+77.3%) | $158.53M(-473.2%) |
| Sep 2020 | - | $34.91M(+6.2%) | -$42.48M(+18.3%) |
| Jun 2020 | - | $32.86M(+13.8%) | -$35.92M(+58.7%) |
| Mar 2020 | - | $28.87M(-120.8%) | -$22.64M(-19.1%) |
| Dec 2019 | -$27.97M(-67.9%) | -$139.13M(-435.5%) | -$27.97M(-122.7%) |
| Sep 2019 | - | $41.47M(-10.1%) | $123.43M(-326.5%) |
| Jun 2019 | - | $46.15M(+96.0%) | -$54.51M(-35.3%) |
| Mar 2019 | - | $23.54M(+91.8%) | -$84.21M(-3.4%) |
| Dec 2018 | -$87.15M(-20.8%) | $12.28M(-109.0%) | -$87.15M(-58.7%) |
| Sep 2018 | - | -$136.47M(-930.2%) | -$210.87M(+210.3%) |
| Jun 2018 | - | $16.44M(-20.2%) | -$67.96M(-16.5%) |
| Mar 2018 | - | $20.61M(-118.5%) | -$81.42M(-26.0%) |
| Dec 2017 | -$110.04M(+2053.5%) | -$111.45M(-1829.8%) | -$110.04M(-7921.2%) |
| Sep 2017 | - | $6.44M(+116.0%) | $1.41M(-127.9%) |
| Jun 2017 | - | $2.98M(-137.2%) | -$5.04M(-37.2%) |
| Mar 2017 | - | -$8.02M | -$8.02M |
| Dec 2016 | -$5.11M(>+9900.0%) | - | - |
| Dec 2015 | -$17.00K | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFI year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFI year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFI year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of RYTM is -$48.17M
What is the all time high annual CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from investing activities is $158.53M
What is Rhythm Pharmaceuticals annual CFI year-on-year change?
Over the past year, RYTM annual cash flow from investing activities has changed by -$42.51M (-750.36%)
What is Rhythm Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of RYTM is $24.81M
What is the all time high quarterly CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from investing activities is $72.52M
What is Rhythm Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, RYTM quarterly cash flow from investing activities has changed by -$5.24M (-17.43%)
What is Rhythm Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of RYTM is -$53.41M
What is the all time high TTM CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from investing activities is $178.53M
What is Rhythm Pharmaceuticals TTM CFI year-on-year change?
Over the past year, RYTM TTM cash flow from investing activities has changed by -$59.33M (-1002.06%)